Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma

Abstract Objectives Glioblastoma is a highly aggressive and fatal brain malignancy, and effective targeted therapies are required. The combination of standard treatments including surgery, chemotherapy and radiotherapy is not curative. Chimeric antigen receptor (CAR) T cells are known to cross the b...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, Valeria Arcucci, Margareta Go, Hannah E Hughes‐Parry, Pete Smith, Melissa J Call, Ryan S Cross, Misty R Jenkins
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2023-01-01
Saila:	Clinical & Translational Immunology
Gaiak:	CAR T cells chimeric antigen receptor EGFRvIII glioblastoma immunotherapy
Sarrera elektronikoa:	https://doi.org/10.1002/cti2.1440
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!